PetIQ Inc (PETQ)
20.15
+0.18
(+0.90%)
USD |
NASDAQ |
May 20, 16:00
20.12
-0.04
(-0.17%)
After-Hours: 20:00
PetIQ Net Income (Quarterly): 14.91M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 14.91M |
December 31, 2023 | -17.49M |
September 30, 2023 | 0.451M |
June 30, 2023 | 9.468M |
March 31, 2023 | 9.699M |
December 31, 2022 | -6.835M |
September 30, 2022 | -49.14M |
June 30, 2022 | 4.632M |
March 31, 2022 | 3.131M |
December 31, 2021 | -14.12M |
September 30, 2021 | -7.902M |
June 30, 2021 | 4.026M |
March 31, 2021 | 2.033M |
December 31, 2020 | -8.826M |
September 30, 2020 | -70.25M |
June 30, 2020 | -1.476M |
March 31, 2020 | -2.103M |
Date | Value |
---|---|
December 31, 2019 | -10.99M |
September 30, 2019 | -5.89M |
June 30, 2019 | 3.815M |
March 31, 2019 | 1.611M |
December 31, 2018 | -3.474M |
September 30, 2018 | 2.221M |
June 30, 2018 | 2.499M |
March 31, 2018 | -2.028M |
December 31, 2017 | -3.267M |
September 30, 2017 | -0.226M |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.597M |
March 31, 2016 | -0.305M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-70.25M
Minimum
Sep 2020
14.91M
Maximum
Mar 2024
-7.143M
Average
-1.790M
Median
Net Income (Quarterly) Benchmarks
Dynavax Technologies Corp | -8.721M |
Pacira BioSciences Inc | 8.979M |
Supernus Pharmaceuticals Inc | 0.124M |
Esperion Therapeutics Inc | 61.02M |
Deciphera Pharmaceuticals Inc | -45.08M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 308.44M |
Total Expenses (Quarterly) | 284.11M |
EPS Diluted (Quarterly) | 0.48 |
Enterprise Value | 1.016B |
Gross Profit Margin (Quarterly) | 24.17% |
Profit Margin (Quarterly) | 4.83% |
Earnings Yield | 1.09% |
Operating Earnings Yield | 9.92% |
Normalized Earnings Yield | 3.684 |